PTPN11 and non-small cell lung carcinoma: CRISPR screens have identified negative (MYC, SHP2, mTOR, RPS6, CDK1, CDK2, CDK4/6, and RB1) and positive (KEAP1 and CBL) regulators of adagrasib sensitivity in NSCLC cells [176].